Cancer Drug Discovery Center of Economic Excellence Endowed Chairs

Actively Recruiting
SmartState Endowed Chair
in Lipidomics and Pathobiology
Medical University of South Carolina (MUSC)

Actively Recruiting
Endowed Chair in
Lipidomics and Drug Discovery
Medical University of South Carolina (MUSC)

The Medical University of South 
Carolina recently opened a state-of-
the-art Drug Discovery Building, part 
of the James E. Clyburn Research 
Center. More>

Would You Like To Book A SmartState Program Speaker?

Click Here

Lipidomics, Pathobiology and Therapy

Center of Economic Excellence

Inception

2009

Award Amount

$5 million

Extramural Research Funding

$19.7 million

University Partner

Medical University of South Carolina (MUSC)
Clemson University

Private Sector Partner

Multiple Industry Partners

The Lipidomics, Pathobiology and Therapy Center leverages the Medical University of South Carolina’s (MUSC) strength in the area of lipidomics, which involves the study of lipids within biological systems. Lipids, along with carbohydrates and proteins, are among the principle components of living cells and include fats, waxes, and similar compounds.

The Center translates the basic lipidomics research occurring at MUSC into an understanding of lipids’ role in health problems such as cancer, inflammation and diabetes. Researchers are using the findings to identify new targets for diagnostics and treatments for these illnesses.

The Center has filed three invention disclosures, two focused on detection and monitoring of bladder cancer and one focused on blood screenings and identification of disease biomarkers. Its researchers are working to generate additional external funding for MUSC’s lipid research program and could lead to the development of patents that can be licensed, sold, or serve as the basis for new start-up companies.

Connect With SmartState Endowed Chairs To Learn About Their Research And Business Development Opportunities

Click Here